4//SEC Filing
ALEXION PHARMACEUTICALS INC 4
Accession 0000899866-14-000188
CIK 0000899866operating
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 6:33 PM ET
Size
11.7 KB
Accession
0000899866-14-000188
Insider Transaction Report
Form 4
Rummelt Andreas
Director
Transactions
- Sale
Common Stock, par value $.0001 per share
2014-08-25$170.53/sh−5,052$861,518→ 12,786 total - Exercise/Conversion
Option to Purchase Common Stock
2014-08-25$49.43/sh−1,393$68,856→ 0 totalExercise: $49.43From: 2011-08-11Exp: 2021-05-11→ Common Stock, par value $.0001 per share (1,393 underlying) - Exercise/Conversion
Common Stock, par value $.0001 per share
2014-08-25$49.43/sh+1,393$68,856→ 17,838 total - Exercise/Conversion
Option to Purchase Common Stock
2014-08-25$24.36/sh−3,659$89,133→ 0 totalExercise: $24.36From: 2011-02-23Exp: 2020-02-23→ Common Stock, par value $.0001 per share (3,659 underlying) - Exercise/Conversion
Common Stock, par value $.0001 per share
2014-08-25$24.36/sh+3,659$89,133→ 16,445 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $170.46 - $170.62. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
Documents
Issuer
ALEXION PHARMACEUTICALS INC
CIK 0000899866
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000899866
Filing Metadata
- Form type
- 4
- Filed
- Aug 26, 8:00 PM ET
- Accepted
- Aug 27, 6:33 PM ET
- Size
- 11.7 KB